A recent publication has unveiled five-year data demonstrating outstanding results for knee osteoarthritis patients treated with the MISHA® Knee System. This innovative knee treatment has shown remarkable efficacy, significantly improving patient mobility and reducing pain over the long term. According to the study, patients experienced enhanced joint function, highlighting the system’s potential as a superior alternative to traditional treatment methods. This significant breakthrough in osteoarthritis care could transform patient outcomes, offering relief and better quality of life for millions suffering from debilitating knee conditions. Health practitioners and patients alike are encouraged by the data, emphasizing the MISHA® Knee System’s role in advancing orthopedic treatment standards. By integrating this leading-edge technology, the healthcare industry can anticipate a new benchmark in managing knee osteoarthritis effectively.
Ortho Spine NewsNew data shows CLYM116 reduces key IgA nephropathy biomarkers by ~70%, supporting a 12-week dosing regimen
October 24, 2026
New data released by CLIMB Bio and MabWorks reveals that their investigational drug CLYM116 significantly reduces critical biomarkers associated with IgA nephropathy by approximately 70%.